PLX-100 | Interleukin Related interleukin-related.com

Product Name :
PLX-100

Search keywords :
TPP1

drugId :
null

Target Vo:
Tripeptidyl Peptidase 1

Target Vo Short Name :
TPP1

Moa_Name:
Tripeptidyl Peptidase 1 stimulants

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Polaryx Therapeutics

Active Company_Name :
Polaryx Therapeutics

Active Indication_Name:
Niemann-Pick Disease, Type A

In Active Indication_Name:

Termination Status :

China Termination Status :

Highest Status:
Phase 1 Clinical

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
BRD4 Antibody
Hexokinase I Antibody (YA739)
CD41 Antibody: CD41 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 113 kDa, targeting to CD41. It can be used for WB,IHC-P assays with tag free, in the background of Human.

Author: Interleukin Related

Related Posts